WRBY (Warby Parker Inc.) Stock Financials & Earnings | Market Cap Arena

WRBY (Warby Parker Inc.) Stock Financials & Earnings | Market Cap Arena

WRBYWarby Parker Inc.

Mkt Cap$3B

Healthcare·Medical - Instruments & Supplies·🇺🇸 United States·NYSE

Revenue (TTM)$872M

Net Income (TTM)$2M

EPS (TTM)$0.01

Free Cash Flow (TTM)$44M

Gross Margin54.0%

Op. Margin-0.6%

Net Margin0.2%

FCF Margin5.0%

P/S Ratio (TTM)3.7x

P/E Ratio (TTM)1949.8x

YoY Rev Growth+13.0%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$172M	$95M	-$12M
Q2 23	$166M	$91M	-$18M
Q3 23	$170M	$93M	-$20M
Q4 23	$162M	$87M	-$22M
Q1 24	$200M	$110M	-$5M
Q2 24	$188M	$102M	-$9M
Q3 24	$192M	$105M	-$7M
Q4 24	$191M	$103M	-$9M
Q1 25	$224M	$126M	$2M
Q2 25	$214M	$114M	-$5M
Q3 25	$222M	$120M	$4M
Q4 25	$212M	$111M	-$7M

Valuation

Quarter	P/S	P/E
Q1 23	5.2x	—
Q2 23	5.1x	—
Q3 23	4.9x	—
Q4 23	4.8x	—
Q1 24	4.6x	—
Q2 24	4.4x	—
Q3 24	4.3x	—
Q4 24	4.1x	—
Q1 25	4.0x	—
Q2 25	3.9x	—
Q3 25	3.8x	4462.4x
Q4 25	3.7x	1949.8x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	$9M	-$4M
Q2 23	$19M	$7M
Q3 23	$20M	$4M
Q4 23	$14M	$92K
Q1 24	$20M	$5M
Q2 24	$32M	$14M
Q3 24	$27M	$13M
Q4 24	$20M	$2M
Q1 25	$29M	$13M
Q2 25	$40M	$24M
Q3 25	$18M	-$2M
Q4 25	$23M	$8M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$12M
Q2 23	$12M
Q3 23	$15M
Q4 23	$14M
Q1 24	$14M
Q2 24	$18M
Q3 24	$14M
Q4 24	$18M
Q1 25	$16M
Q2 25	$16M
Q3 25	$19M
Q4 25	$15M

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	+12.2%	-1.4%
Q2 23	+11.0%	+1.4%
Q3 23	+14.2%	+10.0%
Q4 23	+10.5%	+9.0%
Q1 24	+16.3%	+11.2%
Q2 24	+13.3%	+7.0%
Q3 24	+13.3%	+5.0%
Q4 24	+17.8%	+9.1%
Q1 25	+11.9%	+7.9%
Q2 25	+13.9%	+11.1%
Q3 25	+15.2%	+9.6%
Q4 25	+11.2%	+9.4%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$20M	11.5%
Q2 23	$18M	10.8%
Q3 23	$16M	9.6%
Q4 23	$16M	10.1%
Q1 24	$14M	7.0%
Q2 24	$14M	7.3%
Q3 24	$11M	5.6%
Q4 24	$9M	4.5%
Q1 25	$12M	5.5%
Q2 25	$9M	4.1%
Q3 25	$0	0.0%
Q4 25	$6M	3.0%

OpEx Breakdown

Quarter	SG&A
Q1 23	$107M
Q2 23	$109M
Q3 23	$112M
Q4 23	$109M
Q1 24	$115M
Q2 24	$111M
Q3 24	$111M
Q4 24	$113M
Q1 25	$120M
Q2 25	$114M
Q3 25	$116M
Q4 25	$118M

Revenue Segments

Quarter	Eyewear Products	Services And Other
Q1 23	$162M	$10M
Q2 23	$157M	$9M
Q3 23	$160M	$10M
Q4 23	$149M	$13M
Q1 24	$188M	$12M
Q2 24	$174M	$14M
Q3 24	$176M	$17M
Q1 25	$211M	$13M
Q2 25	$202M	$13M
Q3 25	$207M	$14M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$204M	$0	$204M
Q2 23	$213M	$0	$213M
Q3 23	$216M	$0	$216M
Q4 23	$217M	$0	$217M
Q1 24	$220M	$0	$220M
Q2 24	$238M	$0	$238M
Q3 24	$251M	$0	$251M
Q4 24	$254M	$0	$254M
Q1 25	$265M	$0	$265M
Q2 25	$286M	$0	$286M
Q3 25	$280M	$0	$280M
Q4 25	$286M	$0	$286M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	116M	+0.4%
Q2 23	117M	+0.5%
Q3 23	118M	+1.0%
Q4 23	119M	+0.5%
Q1 24	119M	+0.5%
Q2 24	120M	+0.8%
Q3 24	121M	+0.7%
Q4 24	121M	+0.4%
Q1 25	125M	+2.7%
Q2 25	123M	-1.7%
Q3 25	125M	+1.9%
Q4 25	123M	-1.4%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 19	—	—
FY 20	—	—
FY 21	$302K	2K
FY 22	$197K	3K
FY 23	$192K	3K
FY 24	$204K	4K
FY 25	$216K	4K